Involve primary-care doctor in retinal artery occlusion

Article

Referral to a primary-care physician is a critical component in the care of patients with a retinal artery occlusion because the ophthalmic event usually is a manifestation of a systemic disease, which by itself is associated with increased morbidity and mortality, according to experts.

Editor's Note: The February, March, and April issues of Optometry Times will explore why and how optometrists should look at patients globally in terms of their overall systemic health. Further emphasis will be placed on working collaboratively with colleagues in primary care and retina to ensure that all treatable conditions are addressed and to help patients maintain optimal vision.

In this three-part series, Advanstar Communications' Action for Outcomes initiative returns, this time with an in-depth look at vascular conditions. As well as serving as a wake-up call, the action plan emphasizes core competencies, best practices, and shared responsibility among all stakeholders in the patient's health-care ecosystem. An interdisciplinary approach to addressing this matter will provide specific knowledge and practical strategies to improve the treatment of patients with these conditions.

"The importance of determining and addressing the underlying cause of retinal arterial occlusive disease is underscored by available data that show post-event mortality rates of [about] 15% at 1 year and 55% after 7 years," said Dr. Gurwood, professor of clinical sciences, The Eye Institute of the Pennsylvania College of Optometry, Salus University, Philadelphia.

"Heyreh dispels the myth that an embolus does not have to be completely lodged in the vessel for occlusion to occur," he said. "It has to be stuck like a cork in a wine bottle. If the occlusion is not complete and blood can flow around the obstruction, patients will remain unaware of their precarious position."

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Presenters from the Collaborative Care Symposium 2025 give their key takeaways from their presentations.
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
© 2025 MJH Life Sciences

All rights reserved.